These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39212766)

  • 21. Moderately Elevated Homocysteine Does Not Contribute to Thoracic Aortic Aneurysm in Mice.
    Roohi J; Kang B; Bernard D; Bedja D; Dietz HC; Brody LC
    J Nutr; 2017 Jul; 147(7):1290-1295. PubMed ID: 28539414
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients.
    Yin 殷晓科 X; Wanga S; Fellows AL; Barallobre-Barreiro J; Lu R; Davaapil H; Franken R; Fava M; Baig F; Skroblin P; Xing Q; Koolbergen DR; Groenink M; Zwinderman AH; Balm R; de Vries CJM; Mulder BJM; Viner R; Jahangiri M; Reinhardt DP; Sinha S; de Waard V; Mayr M
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1859-1873. PubMed ID: 31315432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
    Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
    Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FN (Fibronectin)-Integrin α5 Signaling Promotes Thoracic Aortic Aneurysm in a Mouse Model of Marfan Syndrome.
    Chen M; Cavinato C; Hansen J; Tanaka K; Ren P; Hassab A; Li DS; Youshao E; Tellides G; Iyengar R; Humphrey JD; Schwartz MA
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):e132-e150. PubMed ID: 36994727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
    Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
    J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
    Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome.
    Marque V; Kieffer P; Gayraud B; Lartaud-Idjouadiene I; Ramirez F; Atkinson J
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1184-9. PubMed ID: 11451749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aortic dilatation in Marfan syndrome: role of arterial stiffness and fibrillin-1 variants.
    Salvi P; Grillo A; Marelli S; Gao L; Salvi L; Viecca M; Di Blasio AM; Carretta R; Pini A; Parati G
    J Hypertens; 2018 Jan; 36(1):77-84. PubMed ID: 29210860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
    Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
    J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of thoracic spine deformity and cardiovascular disease in a mouse model for Marfan syndrome.
    de Souza RB; Farinha-Arcieri LE; Catroxo MHB; Martins AMCRPDF; Tedesco RC; Alonso LG; Koh IHJ; Pereira LV
    PLoS One; 2019; 14(11):e0224581. PubMed ID: 31725753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm.
    Gibson C; Nielsen C; Alex R; Cooper K; Farney M; Gaufin D; Cui JZ; van Breemen C; Broderick TL; Vallejo-Elias J; Esfandiarei M
    J Appl Physiol (1985); 2017 Jul; 123(1):147-160. PubMed ID: 28385916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losartan Attenuates Degradation of Aorta and Lung Tissue Micromechanics in a Mouse Model of Severe Marfan Syndrome.
    Lee JJ; Galatioto J; Rao S; Ramirez F; Costa KD
    Ann Biomed Eng; 2016 Oct; 44(10):2994-3006. PubMed ID: 27090893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
    Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
    Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cystic disease in the Fbn1
    Hibender S; Wanga S; van der Made I; Vos M; Mulder BJ; Balm R; de Vries CJ; de Waard V
    Cardiovasc Pathol; 2019; 38():1-6. PubMed ID: 30359839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional changes in elastic fiber organization and transforming growth factor β signaling in aortas from a mouse model of marfan syndrome.
    Howell DW; Popovic N; Metz RP; Wilson E
    Cell Tissue Res; 2014 Dec; 358(3):807-19. PubMed ID: 25238995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrative systems approach identifies novel candidates in Marfan syndrome-related pathophysiology.
    Bhushan R; Altinbas L; Jäger M; Zaradzki M; Lehmann D; Timmermann B; Clayton NP; Zhu Y; Kallenbach K; Kararigas G; Robinson PN
    J Cell Mol Med; 2019 Apr; 23(4):2526-2535. PubMed ID: 30677223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical behavior and matrisome gene expression in the aneurysm-prone thoracic aorta of newborn lysyl oxidase knockout mice.
    Staiculescu MC; Kim J; Mecham RP; Wagenseil JE
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H446-H456. PubMed ID: 28550176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative proteomics reveal lineage-specific protein profiles in iPSC-derived Marfan syndrome smooth muscle cells.
    Iosef C; Pedroza AJ; Cui JZ; Dalal AR; Arakawa M; Tashima Y; Koyano TK; Burdon G; Churovich SMP; Orrick JO; Pariani M; Fischbein MP
    Sci Rep; 2020 Nov; 10(1):20392. PubMed ID: 33230159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.